acquired
Stage
1
Investors
About
MyoKardia develops targeted therapies for the treatment of serious cardiovascular diseases, focusing on genetic heart conditions.
Explore MyoKardia's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.